Covington-Led Indivior To Buy US Drug Co. Opiant For $145M
London-listed Indivior PLC said on Monday that it is offering to buy Opiant Pharmaceuticals Inc., a U.S. company that develops treatments to combat addiction, in a $145 million all-cash deal that...To view the full article, register now.
Already a subscriber? Click here to view full article